相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenomics in Psychiatry: From Therapeutic Drug Monitoring to Genomic Medicine
S. Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Antidepressant pharmacogenetics
Ajeet B. Singh et al.
CURRENT OPINION IN PSYCHIATRY (2014)
Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response
Katharina Domschke et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Impact of Genetic Polymorphism on Drug-Drug Interactions Mediated by Cytochromes: A General Approach
Michel Tod et al.
AAPS JOURNAL (2013)
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Regulation and dysregulation of 3′UTR-mediated translational control
Jie Jia et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers
Tara A. Cartwright et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Pharmacogenetics in major depression: A comprehensive meta-analysis
Tomihisa Niitsu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder
Concetta Crisafulli et al.
PSYCHIATRY RESEARCH (2013)
Liver X Receptor Activation Enhances Blood-Brain Barrier Integrity in the Ischemic Brain and Increases the Abundance of ATP-Binding Cassette Transporters ABCB1 and ABCC1 on Brain Capillary Cells
Ayman ElAli et al.
BRAIN PATHOLOGY (2012)
Psychotropic Drug-Drug Interactions Involving P-Glycoprotein
Yumiko Akamine et al.
CNS DRUGS (2012)
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
Stefano Porcelli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review
H-H Tsai et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Apolipoprotein-E Controls Adenosine Triphosphate-Binding Cassette Transporters ABCB1 and ABCC1 on Cerebral Microvessels After Methamphetamine Intoxication
Ayman ElAli et al.
STROKE (2012)
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
A. B. Singh et al.
TRANSLATIONAL PSYCHIATRY (2012)
ABC Transporters in the CNS – An Inventory
A. M.S. Hartz et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project
R. Keers et al.
PHARMACOGENOMICS JOURNAL (2011)
Regional P-Glycoprotein Activity and Inhibition at the Human Blood-Brain Barrier as Imaged by Positron Emission Tomography
S. Eyal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders
Fabien Dutheil et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression
Michael E. Thase et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis
Jay C. Fournier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
MRP1 Polymorphisms Associated With Citalopram Response in Patients With Major Depression
Sung Hee Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Apolipoprotein E Controls ATP-Binding Cassette Transporters in the Ischemic Brain
Ayman ElAli et al.
SCIENCE SIGNALING (2010)
Cediranib (recentin, AZD2171) reverses ABCB1-and ABCC1-mediated multidrug resistance by inhibition of their transport function
Li-yang Tao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
An Integrated Analysis of the Efficacy of Desvenlafaxine Compared with Placebo in Patients with Major Depressive Disorder
Michael E. Thase et al.
CNS SPECTRUMS (2009)
Comparison of the Pharmacokinetics of Venlafaxine Extended Release and Desvenlafaxine in Extensive and Poor Cytochrome P450 2D6 Metabolizers
Sheldon Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Genetically guided prescribing: Hope or hype?
Ajeet Singh et al.
ACTA NEUROPSYCHIATRICA (2008)
Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein
Jun-Sheng Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
ABCC1: a gateway for pharmacological compounds to the ischaemic brain
Ertugrul Kilic et al.
BRAIN (2008)
A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs
Kristian Linnet et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression
Manfred Uhr et al.
NEURON (2008)
Mechanisms of disease: Major depressive disorder
R. H. Belmaker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The Most Conserved Genome Segments for Life Detection on Earth and Other Planets
Thomas A. Isenbarger et al.
ORIGINS OF LIFE AND EVOLUTION OF BIOSPHERES (2008)
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
Masaki Kato et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
A silent polymorphism in the MDR1 gene changes substrate specificity
Chava Kimchi-Sarfaty et al.
SCIENCE (2007)
Implications of ATP-binding cassette transporters for brain pharmacotherapies
Dirk M. Hermann et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia
A Spudich et al.
NATURE NEUROSCIENCE (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Antidepressant action: to the nucleus and beyond
JE Malberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-analysis of original data from 7 randomized controlled trials
ME Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Efficacy of antidepressants in adults
J Moncrieff et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
Inhibition of P-glycoprotein by newer antidepressants
J Weiss et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr1a P-glycoprotein gene disruption
M Uhr et al.
NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
